Cargando…
Non‐Additive Effects of Combined NOX1/4 Inhibition and Calcimimetic Treatment on a Rat Model of Chronic Kidney Disease‐Mineral and Bone Disorder (CKD‐MBD)
Chronic kidney disease‐mineral and bone disorder (CKD‐MBD) increases cardiovascular calcification and skeletal fragility in part by increasing systemic oxidative stress and disrupting mineral homeostasis through secondary hyperparathyroidism. We hypothesized that treatments to reduce reactive oxygen...
Autores principales: | Damrath, John G, Chen, Neal X, Metzger, Corinne E, Srinivasan, Shruthi, O'Neill, Kalisha, Biruete, Annabel, Avin, Keith G, Wallace, Joseph M, Allen, Matthew R, Moe, Sharon M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914155/ https://www.ncbi.nlm.nih.gov/pubmed/35309859 http://dx.doi.org/10.1002/jbm4.10600 |
Ejemplares similares
-
445 The effects of dietary fiber based on fermentability and viscosity on phosphorus absorption and the gut microbiome in chronic kidney disease-mineral and bone disorder
por: Biruete, Annabel, et al.
Publicado: (2023) -
Calcimimetics and outcomes in CKD
por: Drüeke, Tilman B
Publicado: (2013) -
Calcimimetics Alter Periosteal and Perilacunar Bone Matrix Composition and Material Properties in Early Chronic Kidney Disease
por: Damrath, John G., et al.
Publicado: (2022) -
Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats
por: Vorland, Colby J., et al.
Publicado: (2019) -
Calcimimetics in CKD—results from recent clinical studies
por: Schlieper, Georg, et al.
Publicado: (2008)